These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 23000056)
1. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure. Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056 [TBL] [Abstract][Full Text] [Related]
2. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome. Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484 [TBL] [Abstract][Full Text] [Related]
3. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy. Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296 [TBL] [Abstract][Full Text] [Related]
4. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody]. Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599 [TBL] [Abstract][Full Text] [Related]
5. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies. Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485 [TBL] [Abstract][Full Text] [Related]
6. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768 [TBL] [Abstract][Full Text] [Related]
7. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
9. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a. Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061 [TBL] [Abstract][Full Text] [Related]
10. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757 [TBL] [Abstract][Full Text] [Related]
11. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446 [TBL] [Abstract][Full Text] [Related]
12. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792 [TBL] [Abstract][Full Text] [Related]
13. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091 [TBL] [Abstract][Full Text] [Related]
14. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves. Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683 [TBL] [Abstract][Full Text] [Related]
15. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
16. Anti-ganglioside complex antibodies associated with severe disability in GBS. Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161 [TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126 [TBL] [Abstract][Full Text] [Related]
18. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody]. Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085 [TBL] [Abstract][Full Text] [Related]
19. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898 [TBL] [Abstract][Full Text] [Related]
20. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia. Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]